Clinical efficacy and safety: antineoplastic and immunomodulating agents

The European Medicines Agency's scientific guidelines on the clinical evaluation of antineoplastic and immunomodulating agents help medicine developers prepare marketing authorisation applications.
HumanRegulatory and procedural guidanceResearch and developmentScientific guidelines

Share this page